chr6-123393674-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000334268.9(TRDN):c.1055C>T(p.Pro352Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000053 in 1,604,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P352Q) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000334268.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRDN | NM_006073.4 | c.1055C>T | p.Pro352Leu | missense_variant | 13/41 | ENST00000334268.9 | NP_006064.2 | |
TRDN | NM_001251987.2 | c.1058C>T | p.Pro353Leu | missense_variant | 13/21 | NP_001238916.1 | ||
TRDN | NM_001407315.1 | c.998C>T | p.Pro333Leu | missense_variant | 12/20 | NP_001394244.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRDN | ENST00000334268.9 | c.1055C>T | p.Pro352Leu | missense_variant | 13/41 | 1 | NM_006073.4 | ENSP00000333984 | A2 | |
TRDN-AS1 | ENST00000587106.6 | n.55+4199G>A | intron_variant, non_coding_transcript_variant | 5 | ||||||
TRDN | ENST00000662930.1 | c.1058C>T | p.Pro353Leu | missense_variant | 13/21 | ENSP00000499585 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151764Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000765 AC: 18AN: 235388Hom.: 0 AF XY: 0.0000940 AC XY: 12AN XY: 127680
GnomAD4 exome AF: 0.0000551 AC: 80AN: 1452376Hom.: 0 Cov.: 30 AF XY: 0.0000540 AC XY: 39AN XY: 721852
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151764Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74108
ClinVar
Submissions by phenotype
Catecholaminergic polymorphic ventricular tachycardia 1;C3809536:Catecholaminergic polymorphic ventricular tachycardia 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 07, 2021 | - - |
Catecholaminergic polymorphic ventricular tachycardia 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 25, 2022 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 352 of the TRDN protein (p.Pro352Leu). This variant is present in population databases (rs754708708, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with TRDN-related conditions. ClinVar contains an entry for this variant (Variation ID: 1015507). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2023 | The p.P352L variant (also known as c.1055C>T), located in coding exon 13 of the TRDN gene, results from a C to T substitution at nucleotide position 1055. The proline at codon 352 is replaced by leucine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at